Healthcare 2021 off to a great start with M&A boom, PE investments & regulatory stimulus sgblog Feb 2, 2021 0
Healthcare Biosimilars: FDA intervenes to address pervasive challenge of patent web with new Purple Book disclosure requirement sgblog Feb 2, 2021 0
Healthcare COVID-19 vaccines: Global collaborations & concerted scientific effort sets record benchmark for pace of development sgblog Jan 4, 2021 0
Healthcare Lackluster year for biosimilars – marked by regulatory and development delays sgblog Jan 4, 2021 0
Healthcare Patient friendly drug delivery – Adapting to the new normal & sustainable impact sgblog Jan 4, 2021 0
Healthcare Finally, long overdue focus on manufacturing resilience across geographic borders sgblog Jan 4, 2021 0
Grow Beyond 
